All Reports Events Blogs Videos
Showing 21 results
  • NEW
    Blog
    Aug. 03, 2026

    In Part 1 of this series, Why the Migration Clock Has Already Started, we explained why Banking, Financial Services and Insurance (BFSI) enterprises cannot wait for a formal mandate to begin their Post-quantum Cryptography (PQC) migration and estimated a roughly US$7 billion spending opportunity across the top…
  • Blog
    July 21, 2026

    Current state of cryptography in BFSI  Banks, insurers, and capital markets enterprises have been using cryptography for a long time across every important part of their business. It protects everything from mobile payments to complex trading platforms and third-party connections.  …
  • LinkedIn Live
    Nov. 19, 2025

    In an evolving landscape where analyst relations (AR) shape market perception and business success, leaders continued to look for proven tactics embraced by experienced AR professionals. Everest Group’s Katrina Menzigian, along with industry experts from other…
  • PEAK Matrix®
    June 09, 2025

    The life sciences industry is undergoing rapid digital transformation, fueled by the need for greater agility, regulatory compliance, and patient-centric operations. Enterprise platforms such as SAP, Oracle, and Salesforce have evolved from back-end systems of record…
  • May 12, 2025

    Introduction: The evolving landscapeArtificial Intelligence (AI) is revolutionizing industries, and Private Equity (PE) firms are rapidly adapting to harness its benefits. With record-breaking fundraising and considerable dry powder providing a strong capital base, PE firms are…
  • State of the Market
    May 07, 2025

    The life sciences R&D engine is rapidly digitizing, and clinical development software now sits at its center. This report sizes the global clinical trials technology market at nearly US$6.5 billion for 2025 (8-10% CAGR) and dissects…
  • PEAK Matrix®
    Nov. 11, 2024

    Clinical Trial Management Systems (CTMS) are vital to modern clinical research, offering essential tools to manage and track all operational aspects of the trial process. Clinical trials’ increasing complexity, the growing data volume, and the need…
  • Market Insights™
    Oct. 16, 2024

  • Market Insights™
    Sep. 26, 2024

  • Market Insights™
    Sep. 26, 2024

  • Thematic Report
    Sep. 23, 2024

    In the dynamic life sciences clinical development field, patient engagement has emerged a vital innovation and success driver. As clinical research evolves, integrating patient perspectives and active participation has become a transformative force, significantly enhancing clinical…
  • Viewpoint
    Sep. 05, 2024

    Drug development is a complex, time-consuming, and expensive process. The average cost to develop a new drug has increased from US$1.3 million in 2013 to US$2.3 billion in 2022. This cost increase poses a significant challenge…
  • Viewpoint
    July 03, 2024

    Gen AI can create diverse content and data formats, revolutionizing the AI landscape and transforming businesses. The pharmaceutical industry can use gen AI to sift through vast clinical data volumes, enabling trial protocols’ drafting and improving clinical…
  • Provider Compendium
    Feb. 26, 2024

    Decentralized Clinical Trials (DCTs) are transforming the landscape of clinical research by leveraging digital technologies to facilitate remote patient participation. This patient-centric approach not only benefits participants but also ensures more inclusive and robust study results…
  • PEAK Matrix®
    Dec. 08, 2023

    Decentralized Clinical Trials (DCTs) are transforming the landscape of clinical research by harnessing digital technologies to facilitate remote patient participation. This patient-centric approach not only benefits participants but also ensures more inclusive and robust study results…
  • Provider Compendium
    Aug. 29, 2023

    The pandemic accelerated the need to extract value from data due to the substantial increase in data generation from various clinical sources, characterized by high veracity, variety, and volume. As a result, the adoption of clinical…
  • Aug. 07, 2020

    GBS Cost and Performance Benchmarks Book is available only to GBS & Shared Services (GBS/SS) members. For information on membership, please contact us The Cost and Performance Benchmarks Book is an off-the-shelf reference for GBS professionals…